The global health burden ofthe major hemoglobin disorders, sickle cell anemia and B-thalassemia, is enormous and predicted to grow. Increased fetal hemoglobin (HbF) greatly ameliorates the morbidity and mortality of these disorders. A long sought goal is directed reactivation of HbF expression in adults with hemoglobin disorders. Largely through human genetic studies, substantial progress has been made in understanding the regulatory factors controlling the fetal (a2Y2) to adult (a2B2) switch and how HbF silencing is maintained in the adult. A premise of the proposed work is that fundamental findings on hemoglobin switching provide a platform for establishing mechanism-based approaches to the identification of small molecules that induce HbF in adult erythroid cells. If successful in this overall goal, new therapies may be developed for treatment of patients with the major hemoglobin disorders. This proposal encompasses three independent, but interrelated, aims. First, the mechanisms by which the gene encoding BCL11A, a central repressor of HbF expression, is regulated will be explored using high-resolution nascent transcription mapping, chromatin occupancy, and assays of putative cis-regulatory elements. Down-regulation of BCL11A expression or function provides a direct route to relief from HbF silencing. An additional goal of this aim isalso to determine how genetic variation in the BCL1 IA gene influences expression of BCL11A itself, as this knowledge may lead to approaches to direct down-regulation of BCL11A expression. Second, high throughput screening for small molecule inducers of HbF will be performed in cultured erythroid cells, and promising "hits" will be evaluated further for the pathways affected and for optimization as therapeutics. Third, screens with genome-wide short hairpin RNA (shRNA) and open reading frame (ORF) libraries will be performed to identify novel genes/pathways for induction of silenced HbF in primary human CD34 derived erythroid progenitors. Through the multidisciplinary approaches in this proposal basic findings on HbF regulation will be translated to advance identification and development of new therapeutics for patients with hemoglobin disorders.

Public Health Relevance

This project addresses the reactivation of fetal hemoglobin (HbF) in adult erythroid cells. The topic is directly relevant to human hemoglobin disorders, as reactivation of HbF would constitute an effective treatment strategy for affected individuals.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL032262-33
Application #
8693642
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
33
Fiscal Year
2014
Total Cost
$421,361
Indirect Cost
$179,199
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Pishesha, Novalia; Thiru, Prathapan; Shi, Jiahai et al. (2014) Transcriptional divergence and conservation of human and mouse erythropoiesis. Proc Natl Acad Sci U S A 111:4103-8
Alvarez-Dominguez, Juan R; Hu, Wenqian; Gromatzky, Austin A et al. (2014) Long noncoding RNAs during normal and malignant hematopoiesis. Int J Hematol 99:531-41
Ludwig, Leif S; Gazda, Hanna T; Eng, Jennifer C et al. (2014) Altered translation of GATA1 in Diamond-Blackfan anemia. Nat Med 20:748-53
Chen, Cynthia; Lodish, Harvey F (2014) Global analysis of induced transcription factors and cofactors identifies Tfdp2 as an essential coregulator during terminal erythropoiesis. Exp Hematol 42:464-76.e5
Hagedorn, Elliott J; Durand, Ellen M; Fast, Eva M et al. (2014) Getting more for your marrow: boosting hematopoietic stem cell numbers with PGE2. Exp Cell Res 329:220-6
Yien, Yvette Y; Robledo, Raymond F; Schultz, Iman J et al. (2014) TMEM14C is required for erythroid mitochondrial heme metabolism. J Clin Invest 124:4294-304
Cheng, Albert W; Shi, Jiahai; Wong, Piu et al. (2014) Muscleblind-like 1 (Mbnl1) regulates pre-mRNA alternative splicing during terminal erythropoiesis. Blood 124:598-610
Shmukler, Boris E; Reimold, Fabian R; Heneghan, John F et al. (2014) Molecular cloning and functional characterization of zebrafish Slc4a3/Ae3 anion exchanger. Pflugers Arch 466:1605-18
Hu, Wenqian; Yuan, Bingbing; Lodish, Harvey F (2014) Cpeb4-mediated translational regulatory circuitry controls terminal erythroid differentiation. Dev Cell 30:660-72
Chung, Jacky; Anderson, Sheila A; Gwynn, Babette et al. (2014) Iron regulatory protein-1 protects against mitoferrin-1-deficient porphyria. J Biol Chem 289:7835-43

Showing the most recent 10 out of 113 publications